Trial Profile
Open-Label Pharmacokinetic Study to Evaluate the Steady-State Venous and Capillary Plasma Concentrations of Five Antipsychotics: Aripiprazole, Olanzapine, Paliperidone, Quetiapine and Risperidone
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2016
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine (Primary) ; Paliperidone (Primary) ; Quetiapine (Primary) ; Risperidone (Primary)
- Indications Bipolar disorders; Depressive disorders; Psychotic disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 12 Nov 2016 New trial record
- 01 Nov 2016 Results published in the Clinical Pharmacology in Drug Development